Business:
Cancer Treatments
Drug notes:
AB-2100 Clin0 solid tumors
About:
ArsenalBio is developing programmable immune cell therapies to defeat cancer. CAR T-cell therapies are a recent revelation in developing targeted immune therapies for cancer. However, they have high risk and are high cost for development. Using multi-omics, gene editing technology and synthetic biology, ArsenalBio’s cell therapeutics are optimized for expansion, memory and persistence in vivo to reduce the number of cell infusions and minimize off-target effects. ArsenalBio is therefore enhancing the safety, efficacy and availability of these cell therapies for cancer patients. ArsenalBio has a multi program discovery collaboration with Bristol Myers Squibb to advance T cell therapies for solid tumors.
FP&A Manager (25106-R-840-FIN) South San Francisco|27 days ago
Director, Process Engineering (25105-T-680-PS) Hayward|84 days ago
Senior Scientist, Discovery Immunology (25102-R-67... South San Francisco|100+ days ago
Director of GMP Procurement & Planning (25034-... Hayward|100+ days ago
Don't See Your Role Below? South San Francisco|100+ days ago